Works matching IS 13524585 AND DT 2023 AND VI 29 AND IP 7
Results: 20
MS becomes a treatable disease: 30 years later.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 789, doi. 10.1177/13524585231174781
- By:
- Publication type:
- Article
Leigh syndrome mimicking neuromyelitis optica spectrum disorder (NMOSD).
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 889, doi. 10.1177/13524585231172950
- By:
- Publication type:
- Article
Two cases of MT-ND5 -related mitochondrial disorder misdiagnosed as seronegative neuromyelitis optica spectrum disorder.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 892, doi. 10.1177/13524585231172947
- By:
- Publication type:
- Article
Presymptomatic MS or radiologically isolated syndrome (RIS) should be actively monitored and treated – NO.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 795, doi. 10.1177/13524585231172945
- By:
- Publication type:
- Article
Mitochondrial diseases mimicking NMOSD.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 897, doi. 10.1177/13524585231172944
- By:
- Publication type:
- Article
Presymptomatic MS or radiologically isolated syndrome should be actively monitored and treated: Yes.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 793, doi. 10.1177/13524585231172943
- By:
- Publication type:
- Article
Presymptomatic MS or radiologically isolated syndrome should be actively monitored and treated: Commentary.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 797, doi. 10.1177/13524585231172941
- By:
- Publication type:
- Article
The impact of cigarette smoking on cognitive processing speed and brain atrophy in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 846, doi. 10.1177/13524585231172490
- By:
- Publication type:
- Article
Pediatric multiple sclerosis: The 2022 ECTRIMS lecture.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 772, doi. 10.1177/13524585231171047
- By:
- Publication type:
- Article
PACTRIMS 2022.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. NP1, doi. 10.1177/13524585231169570
- Publication type:
- Article
Sleep-disordered breathing and neurocognitive function in multiple sclerosis: Differential associations across cognitive domains.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 832, doi. 10.1177/13524585231169465
- By:
- Publication type:
- Article
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 856, doi. 10.1177/13524585231167515
- By:
- Publication type:
- Article
Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 799, doi. 10.1177/13524585231166834
- By:
- Publication type:
- Article
Employment status, productivity loss, and associated factors among people with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 866, doi. 10.1177/13524585231164295
- By:
- Publication type:
- Article
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 884, doi. 10.1177/13524585231161253
- By:
- Publication type:
- Article
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 875, doi. 10.1177/13524585231151951
- By:
- Publication type:
- Article
Deep gray matter substructure volumes and depressive symptoms in a large multiple sclerosis cohort.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 809, doi. 10.1177/13524585221148144
- By:
- Publication type:
- Article
Towards a phenotypic understanding of multiple sclerosis depression.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 769, doi. 10.1177/13524585221148143
- By:
- Publication type:
- Article
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 779, doi. 10.1177/13524585221147635
- By:
- Publication type:
- Article
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study).
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 819, doi. 10.1177/13524585231151212
- By:
- Publication type:
- Article